Theravance Biopharma Inc. (TBPH)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 8,511,350 $72,176,248 +22% 9.11%
2. 7,457,060 $63,235,869 2.38%
3.
Irenic Capital Management

Adam Katz And Andy Dodge

2,760,948 $23,412,839 2.86%
4.
Newtyn Management

Noah Levy And Eugene Dozortsev

2,124,703 $18,017,481 +30% 3.38%
5. 1,700,000 $14,416,000 +47% 1.05%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.80 999,800 Large Shareholder 9,511,150 2024-08-07 Filing
$8.75 499,324 Large Shareholder 8,511,350 2024-05-01 Filing
$8.75 999,800 Large Shareholder 8,012,026 2024-05-01 Filing
$22.54 1,000 Director 56,757 2018-05-21 Filing
$26.34 4,000 Officer 213,180 2017-08-21 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.00 4,000 335,965 2024-07-10 Filing
$8.71 1,254 311,733 2024-02-22 Filing
$10.29 1,378 331,206 2023-11-21 Filing
$10.22 2,482 346,839 2023-11-14 Filing
$9.03 2,482 334,321 2023-10-16 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,587,834 $51,567,256 0%
2. 3,489,262 $39,219,305 0%
3. 2,168,397 $24,372,782 0.02%
4. 1,390,314 $15,627,129 0%
5. 994,000 $11,173,535 0%
News See All